Cargando…

An updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease

Pulmonary hypertension (PH) is associated with a poor prognosis in left heart disease (LHD). We sought to provide an updated analysis on the association of hemodynamic variables, such as pulmonary vascular resistance (PVR), pulmonary artery compliance (PAC), and diastolic pressure gradient (DPG), wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baratto, Claudia, Caravita, Sergio, Soranna, Davide, Dewachter, Céline, Bondue, Antoine, Zambon, Antonella, Badano, Luigi P., Parati, Gianfranco, Vachiéry, Jean‐Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768568/
https://www.ncbi.nlm.nih.gov/pubmed/36568693
http://dx.doi.org/10.1002/pul2.12145
_version_ 1784854198293102592
author Baratto, Claudia
Caravita, Sergio
Soranna, Davide
Dewachter, Céline
Bondue, Antoine
Zambon, Antonella
Badano, Luigi P.
Parati, Gianfranco
Vachiéry, Jean‐Luc
author_facet Baratto, Claudia
Caravita, Sergio
Soranna, Davide
Dewachter, Céline
Bondue, Antoine
Zambon, Antonella
Badano, Luigi P.
Parati, Gianfranco
Vachiéry, Jean‐Luc
author_sort Baratto, Claudia
collection PubMed
description Pulmonary hypertension (PH) is associated with a poor prognosis in left heart disease (LHD). We sought to provide an updated analysis on the association of hemodynamic variables, such as pulmonary vascular resistance (PVR), pulmonary artery compliance (PAC), and diastolic pressure gradient (DPG), with prognosis in PH‐LHD, through a systematic literature review. Sixteen articles were identified, including 9600 patients with LHD, heterogeneous in terms of age, sex, and etiology of cardiac disease. In this large population, PVR (hazard ratio [HR], 1.07; 95% confidence interval [CI]: 1.05−1.0), DPG (HR, 1.02; 95% CI: 1.01−1.02) and PAC (HR, 0.76; 95% CI: 0.69−0.84) were associated with an increased risk of adverse outcome, albeit with a less solid performance of DPG. Similar results were found when hemodynamic variables were analyzed according to the thresholds commonly applied in clinical practice, or subdividing cohorts according to the underlying LHD. Furthermore, cumulative metanalysis indicated that these results are consistently stable since 2018. Thus, PVR, DPG and PAC have an established prognostic value in PH‐LHD. These results are consistent through the years and unlikely to change with further studies.
format Online
Article
Text
id pubmed-9768568
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97685682022-12-23 An updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease Baratto, Claudia Caravita, Sergio Soranna, Davide Dewachter, Céline Bondue, Antoine Zambon, Antonella Badano, Luigi P. Parati, Gianfranco Vachiéry, Jean‐Luc Pulm Circ Research Articles Pulmonary hypertension (PH) is associated with a poor prognosis in left heart disease (LHD). We sought to provide an updated analysis on the association of hemodynamic variables, such as pulmonary vascular resistance (PVR), pulmonary artery compliance (PAC), and diastolic pressure gradient (DPG), with prognosis in PH‐LHD, through a systematic literature review. Sixteen articles were identified, including 9600 patients with LHD, heterogeneous in terms of age, sex, and etiology of cardiac disease. In this large population, PVR (hazard ratio [HR], 1.07; 95% confidence interval [CI]: 1.05−1.0), DPG (HR, 1.02; 95% CI: 1.01−1.02) and PAC (HR, 0.76; 95% CI: 0.69−0.84) were associated with an increased risk of adverse outcome, albeit with a less solid performance of DPG. Similar results were found when hemodynamic variables were analyzed according to the thresholds commonly applied in clinical practice, or subdividing cohorts according to the underlying LHD. Furthermore, cumulative metanalysis indicated that these results are consistently stable since 2018. Thus, PVR, DPG and PAC have an established prognostic value in PH‐LHD. These results are consistent through the years and unlikely to change with further studies. John Wiley and Sons Inc. 2022-10-01 /pmc/articles/PMC9768568/ /pubmed/36568693 http://dx.doi.org/10.1002/pul2.12145 Text en © 2022 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Baratto, Claudia
Caravita, Sergio
Soranna, Davide
Dewachter, Céline
Bondue, Antoine
Zambon, Antonella
Badano, Luigi P.
Parati, Gianfranco
Vachiéry, Jean‐Luc
An updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease
title An updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease
title_full An updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease
title_fullStr An updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease
title_full_unstemmed An updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease
title_short An updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease
title_sort updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768568/
https://www.ncbi.nlm.nih.gov/pubmed/36568693
http://dx.doi.org/10.1002/pul2.12145
work_keys_str_mv AT barattoclaudia anupdatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT caravitasergio anupdatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT sorannadavide anupdatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT dewachterceline anupdatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT bondueantoine anupdatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT zambonantonella anupdatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT badanoluigip anupdatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT paratigianfranco anupdatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT vachieryjeanluc anupdatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT barattoclaudia updatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT caravitasergio updatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT sorannadavide updatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT dewachterceline updatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT bondueantoine updatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT zambonantonella updatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT badanoluigip updatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT paratigianfranco updatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease
AT vachieryjeanluc updatedmetaanalysisofhemodynamicsmarkersofprognosisinpatientswithpulmonaryhypertensionduetoleftheartdisease